1
Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
Condition(s):Hypertriglyceridemia; Metabolic SyndromeLast Updated:December 15, 2021Completed
Fenofibrate: 242 Clinical Trials, Page 1 of 25
Hide Studies Not Open or Pending
2
Effects of Fenofibrate Therapy in Diabetic Nephropathy
Condition(s):Diabetes Mellitus; Diabetic NephropathiesLast Updated:December 14, 2020Recruiting
3
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:June 14, 2017Terminated
4
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors – Effect of Fenofibrate
Condition(s):Covid19Last Updated:October 15, 2021Recruiting
5
Fenofibrate in Type 2 Diabetes
Condition(s):Diabetes Mellitus, Type IILast Updated:February 8, 2022Completed
6
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
Condition(s):MicroalbuminuriaLast Updated:December 11, 2014Unknown status
7
Evaluation of Fenofibrate on Radiation-induced Skin Injury
Condition(s):RadiodermatitisLast Updated:June 15, 2018Unknown status
8
Fenofibrate for Prevention of DR Worsening
Condition(s):Diabetic RetinopathyLast Updated:April 26, 2022Recruiting
9
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
Condition(s):Diabetic NephropathiesLast Updated:January 24, 2022Recruiting
10
Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
Condition(s):Neonatal JaundiceLast Updated:June 5, 2020Completed